You might say that Marc Benioff and his colleagues — software developers Parker Harris, Dave Moellenhoff, and Frank Dominguez — changed the world when they created Salesforce (CRM) in 1999. Before that, businesses relied on spreadsheets, handwritten notes, and databases to store their information, which effectively kept everything siloed. Sales reps tracked leads in one place while customer service agents logged complaints in another. This fragmentation made it difficult for businesses to understand the ...

Salesforce, Inc. (NYSE:CRM) is among the 12 Tech Stocks with Best Earnings Growth in 2026. On March 3, Salesforce, Inc. (NYSE:CRM) presented at the 2026 Morgan Stanley Technology, Media & Telecom Conference. While highlighting record financial results for FY2026, thanks to the increase in premium SKU adoption, leadership outlined the company’s strategic vision for the next fiscal year at the conference. Although investors worry about market competition and changing business models, the company remains posi ...

Investors have been increasingly thinking about which software companies will benefit as artificial intelligence (AI) moves from experimentation to real-world deployments. One company that could emerge as a major beneficiary is Salesforce (CRM +0.33%). This technology giant is already well positioned to capitalize on the AI-driven transition in the customer relationship management (CRM) industry. Salesforce reported solid financial numbers in fiscal 2026 (ending Jan. 31, 2026). Revenues were up 10% year ove ...

Core Insights - HubSpot, Inc. (HUBS) is experiencing strong user engagement in its customer relationship management platform, leading to a 21% year-over-year increase in subscription revenues to $829 million in Q4, surpassing estimates [1][8] - The company added over 9,800 net new customers in the quarter, bringing the total customer count to 288,706, which is a 16% increase year-over-year [1][8] Subscription Revenue and Customer Growth - Subscription revenues rose to $829 million from $687.3 million, reflecting a 21% increase year-over-year [1][8] - The total customer count increased to 288,706, with a net addition of more than 9,800 customers during the quarter [1][8] Multi-Hub Adoption and Pricing Strategy - HubSpot is seeing steady multi-hub adoption, with 62% of new Pro+ customers adopting multiple hubs at entry, indicating significant cross-selling opportunities [2] - The company has implemented a seat pricing model, which lowers barriers for new customers and encourages service adoption, resulting in a 3% year-over-year increase in average subscription revenues per customer to $11,700 [3] Deal Growth and Enterprise Adoption - Deals with monthly recurring revenues (MRR) above $5,000 grew by 33%, while those above $10,000 MRR increased by 41%, showcasing strong enterprise adoption [4] - Customers with more than 500 seats have increased fivefold, indicating robust demand from larger enterprises [4] Competitive Landscape - HubSpot faces competition from Salesforce, which generated $10.7 billion in subscription and support revenues in Q4, driven by digital transformation and AI integration [5] - Microsoft is also experiencing healthy demand in its CRM segment, with Dynamic 365 revenues surging 19% year-over-year, supported by AI features [6] Valuation and Earnings Estimates - HubSpot's shares currently trade at a price/book ratio of 7.27, higher than the industry average of 4.43 [9] - Earnings estimates for 2026 and 2027 have improved by 7.04% to $12.31 per share and 7.94% to $15.09 per share, respectively [11]

Madam make we often hear these voices on a daily basis outside our college, outside our home, on our streets. But have we really tried understanding them. Did we really listen to the economy and the smartness behind this voices.I teach management and entrepreneurship. Every time I step out of my university, I find teachers smarter than me and they are selling pakoda, onions, chai, etc. on our street. India.It's home to 10 million plus street vendors contributing 14% of urban employment and rupees 80,000 cr ...

Financial Data and Key Metrics Changes - The company reported mixed results, with positive performance in Latin America, Europe, and Africa, but weakness in Chinese white spirits and North America [4] - The company is committed to generating GBP 3 billion in cash this year, with profitability expected to be flat with potential for slight growth [10][11] Business Line Data and Key Metrics Changes - The company is focusing on investing in the competitiveness of its portfolio, particularly in Guinness, to support growth and improve capabilities [5] - The Accelerate program is delivering savings faster than expected, with 40 out of the targeted 50 million GBP achieved in the first half of the fiscal year [21] Market Data and Key Metrics Changes - The U.S. spirits market is experiencing economic pressure on disposable income, which is a significant downward pressure on the spirits category [34] - The company sees an opportunity to reposition prices selectively in the U.S. market to capture a broader consumer base [25][29] Company Strategy and Development Direction - The company is revisiting its strategy, with a focus on enhancing competitiveness and exploring price repositioning opportunities [4][5] - The management emphasizes the need to engage more effectively with customers and improve operational processes to enhance shareholder value [41] Management's Comments on Operating Environment and Future Outlook - The management acknowledges the challenges in the North American market but believes in the potential for recovery as economic conditions improve [34] - The company is committed to a strategic review that will be shared with stakeholders, aiming for a more resilient portfolio that can thrive in varying economic conditions [35][66] Other Important Information - A change in the dividend policy has been announced, allowing for more investment in the business while rebuilding the balance sheet [5][96] - The management is cautious about making any speculative comments regarding potential brand disposals, emphasizing the importance of maintaining brand value [45][46] Q&A Session Summary Question: Is a short-term profit reset needed following the dividend cut? - The management stated they are not guiding into 2027 but are focused on flat profitability with potential growth, emphasizing the need for strategic investments [10][11] Question: Will there be new RTD launches in the next six months? - The management confirmed that the innovation plan for the remainder of the year is set, with no material changes expected [21] Question: How will price repositioning be approached in the U.S.? - The management indicated that price repositioning will be targeted and surgical, focusing on specific brands and market segments [25][29] Question: What is the outlook for the U.S. spirits market? - The management believes that the U.S. spirits category will eventually return to pre-pandemic growth, but they will consider various economic scenarios in their strategy [34] Question: How can Diageo improve customer execution? - The management highlighted the need for better engagement with customers and improving operational processes to enhance service and lower costs [41] Question: Are there plans for major brand disposals? - The management reiterated that they are not actively seeking to sell brands below their value and will focus on strengthening the balance sheet through other means [45][46] Question: What is the company's approach to the GLP-1 impact? - The management noted that while the impact from GLP-1 is currently limited, they will continue to evaluate its potential effects on consumer behavior and the spirits category [84][92]

Salesforce Inc. (NYSE:CRM) is one of the AI stocks that will go to the moon. On February 18, Salesforce Inc. (NYSE:CRM) entered into an agreement to acquire Momentum. The acquisition of the conversational insights and revenue orchestration platform will extend Agentforce 360 and Slackbot abilities to ingest and analyze unstructured data from third-party voice and video channels. Salesforce Inc (CRM) Expands AI Capabilities With Momentum Acquisition Salesforce plans to merge Momentum’s universal ingestion ...

Company Overview - Salesforce, Inc. (CRM) has a market cap of $206.2 billion and is a leader in customer relationship management technology, offering AI-powered solutions such as Agentforce, Data Cloud, Slack, Tableau, and industry-specific applications [1] Financial Performance - Analysts expect Salesforce to report an EPS of $2.14 for fiscal Q4 2026, reflecting a 3.6% decline from $2.22 in the same quarter last year, although the company has exceeded earnings expectations in the past four quarters [2] - For fiscal 2026, analysts predict an EPS of $8.92, which represents a 13.1% increase from $7.89 in fiscal 2025 [3] Stock Performance - Salesforce shares have decreased by 32.2% over the past 52 weeks, underperforming the S&P 500 Index, which gained 13.3%, and the State Street Technology Select Sector SPDR ETF, which returned 21.2% during the same period [4] - Following strong Q3 2026 results, Salesforce shares rose by 3.7%, with reported revenue of $10.26 billion and adjusted EPS of $3.25. The company also raised its full-year 2026 revenue guidance to between $41.45 billion and $41.55 billion, with significant growth in Agentforce and Data 360 ARR, which reached nearly $1.4 billion, up 114% year-over-year [5] Analyst Ratings - The consensus view among analysts on CRM stock remains bullish, with a "Strong Buy" rating overall. Out of 51 analysts, 36 recommend a "Strong Buy," 2 suggest "Moderate Buys," 12 recommend "Holds," and 1 advises a "Strong Sell." The average analyst price target for Salesforce is $331.25, indicating a potential upside of 50.5% from current levels [6]

Core Insights - Salesforce, Inc. (NYSE:CRM) is recognized as one of the top AI stocks to buy, with Piper Sandler reaffirming an Overweight rating and a price target of $315 following strong Q3 results [1] Financial Performance - Q3 revenue reached $10.3 billion, marking a 9% year-over-year increase, with operational cash flow of $2.3 billion, up 17% year-over-year, and free cash flow of $2.2 billion, up 22% year-over-year [2] - The revenue guidance for Q4 exceeds Wall Street expectations, forecasting adjusted earnings per share between $3.02 and $3.04, with revenue projected between $11.13 billion and $11.23 billion [2] Customer Growth and Product Expansion - There was a significant 70% quarter-over-quarter increase in production customers, rising from 800 to approximately 2,200 [3] - The company's annual recurring revenue (ARR) from Agentforce has reached $540 million, representing 1.4% of the subscription run-rate, with nearly 50% of Agentforce bookings coming from existing customers, an increase from 40% in the previous quarter [4] Company Overview - Salesforce, Inc. is a California-based provider of customer relationship management (CRM) technology, established in 1999, offering core products such as Agentforce, Data Cloud, Industries AI, and Slack [5]

Core Insights - Veeva Systems' Vault CRM is a next-generation customer relationship management tool specifically designed for the biopharma sector, integrating compliance, data, and advanced analytics into a unified system [1] - The adoption of Vault CRM by major biopharma companies indicates a shift towards a standardized platform for customer engagement, emphasizing the importance of precision, compliance, and speed in the industry [1][3] Recent Developments - Bristol Myers Squibb adopted Vault CRM in September 2025, aiming to enhance sales team engagement with healthcare providers through AI-driven insights [2] - Gilead Sciences also committed to Vault CRM in September 2025, highlighting its innovative roadmap and ability to scale commercial operations [2] - Merck and Astellas joined the list of adopters in July and June 2025, respectively, with Astellas complementing its strategy with Veeva China CRM [2] Competitive Landscape - Salesforce is advancing its AI capabilities through its Einstein platform, focusing on enhancing productivity across various industries, including healthcare [4] - IQVIA is expanding its AI-enabled platform offerings, particularly in clinical trial optimization and real-world evidence, maintaining relevance for biopharma companies [5]